Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial
- Resource Type
- Article
- Source
- The Lancet Respiratory Medicine; October 2021, Vol. 9 Issue: 10 p1141-1153, 13p
- Subject
- Language
- ISSN
- 22132600; 22132619